Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
The Journal of Sexual Medicine
|
February 24, 2006
The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment
Mustafa F Usta, Muammer Kendirci, Serap Gur, et al.
The Journal of Sexual Medicine
|
February 21, 2024
Temporal gene signature of myofibroblast transformation in Peyronie's disease: first insights into the molecular mechanisms of irreversibility
Marcus M Ilg, Sophie Harding, Alice R Lapthorn, et al.
Gerontology & Geriatric Medicine
|
June 9, 2021
Associations Between Mobile Health Technology use and Self-rated Quality of Life: A Cross-sectional Study on Older Adults with Cognitive Impairment
Line Christiansen, Johan Sanmartin Berglund, Peter Anderberg, et al.
The Journal of Urology
|
January 25, 2003
BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro
Jas S Kalsi, Rowland W Rees, Adrian J Hobbs, et al.
Gastroenterology
|
September 30, 2009
The beta3-adrenoceptor agonist GW427353 (Solabegron) decreases excitability of human enteric neurons via release of somatostatin
Michael Schemann, Nadia Hafsi, Klaus Michel, et al.
European Urology
|
October 23, 2018
Antifibrotic Synergy Between Phosphodiesterase Type 5 Inhibitors and Selective Oestrogen Receptor Modulators in Peyronie's Disease Models
Marcus M Ilg, Marta Mateus, William J Stebbeds, et al.
The Journal of Sexual Medicine
|
August 11, 2020
Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease
Marcus M Ilg, Simon J Stafford, Marta Mateus, et al.
The Journal of Sexual Medicine
|
January 15, 2017
Early Effect of Bariatric Surgery on Urogenital Function in Morbidly Obese Men
Maha Aleid, Asif Muneer, Sara Renshaw, et al.
European Urology Focus
|
May 8, 2021
Single-cell Transcriptomics Uncover a Novel Role of Myeloid Cells and T-lymphocytes in the Fibrotic Microenvironment in Peyronie's Disease
Uros Milenkovic, Bram Boeckx, Diether Lambrechts, et al.
The Journal of Sexual Medicine
|
May 14, 2026
Evaluation of a combination of off-label PDE5 inhibitor and tamoxifen in acute Peyronie's disease
Mohammad Shah, Matthew Megson, Abdullah Al-Mitwalli, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
The Journal of Sexual Medicine
|
February 24, 2006
The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment
Mustafa F Usta, Muammer Kendirci, Serap Gur, et al.
The Journal of Sexual Medicine
|
February 21, 2024
Temporal gene signature of myofibroblast transformation in Peyronie's disease: first insights into the molecular mechanisms of irreversibility
Marcus M Ilg, Sophie Harding, Alice R Lapthorn, et al.
Gerontology & Geriatric Medicine
|
June 9, 2021
Associations Between Mobile Health Technology use and Self-rated Quality of Life: A Cross-sectional Study on Older Adults with Cognitive Impairment
Line Christiansen, Johan Sanmartin Berglund, Peter Anderberg, et al.
The Journal of Urology
|
January 25, 2003
BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro
Jas S Kalsi, Rowland W Rees, Adrian J Hobbs, et al.
Gastroenterology
|
September 30, 2009
The beta3-adrenoceptor agonist GW427353 (Solabegron) decreases excitability of human enteric neurons via release of somatostatin
Michael Schemann, Nadia Hafsi, Klaus Michel, et al.
European Urology
|
October 23, 2018
Antifibrotic Synergy Between Phosphodiesterase Type 5 Inhibitors and Selective Oestrogen Receptor Modulators in Peyronie's Disease Models
Marcus M Ilg, Marta Mateus, William J Stebbeds, et al.
The Journal of Sexual Medicine
|
August 11, 2020
Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease
Marcus M Ilg, Simon J Stafford, Marta Mateus, et al.
The Journal of Sexual Medicine
|
January 15, 2017
Early Effect of Bariatric Surgery on Urogenital Function in Morbidly Obese Men
Maha Aleid, Asif Muneer, Sara Renshaw, et al.
European Urology Focus
|
May 8, 2021
Single-cell Transcriptomics Uncover a Novel Role of Myeloid Cells and T-lymphocytes in the Fibrotic Microenvironment in Peyronie's Disease
Uros Milenkovic, Bram Boeckx, Diether Lambrechts, et al.
The Journal of Sexual Medicine
|
May 14, 2026
Evaluation of a combination of off-label PDE5 inhibitor and tamoxifen in acute Peyronie's disease
Mohammad Shah, Matthew Megson, Abdullah Al-Mitwalli, et al.
Page
of 6